Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
pertuzumab erbb2 tyrosine kinase receptor NA Successful target TTD , DGIDB Breast[MeSHID:D001940]
Malignant neoplasm of breast[MeSHID:D001943]
Neoplasm Metastasis[MeSHID:D009362]
Recurrence (disease attribute)[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.23 approved inhibitor
pertuzumab receptor tyrosine-protein kinase erbb-2 biotech NA drugbank , DGIDB Breast[MeSHID:D001940]
Malignant neoplasm of breast[MeSHID:D001943]
Neoplasm Metastasis[MeSHID:D009362]
Recurrence (disease attribute)[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.23 approved binder,antibody
pertuzumab erbb2 tyrosine kinase receptor NA Successful target TTD , DGIDB Breast[MeSHID:D001940]
Malignant neoplasm of breast[MeSHID:D001943]
Neoplasm Metastasis[MeSHID:D009362]
Recurrence (disease attribute)[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.23 approved antibody
pertuzumab erbb2 tyrosine kinase receptor NA Successful target TTD , DGIDB Breast[MeSHID:D001940]
Malignant neoplasm of breast[MeSHID:D001943]
Neoplasm Metastasis[MeSHID:D009362]
Recurrence (disease attribute)[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.23 approved unknown
pertuzumab receptor tyrosine-protein kinase erbb-2 biotech NA drugbank , DGIDB Breast[MeSHID:D001940]
Malignant neoplasm of breast[MeSHID:D001943]
Neoplasm Metastasis[MeSHID:D009362]
Recurrence (disease attribute)[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.23 approved binder,antibody,inhibitor
click here to return to the previous page